e.l.f.(US:ELF) Prnewswireยท2025-09-15 00:30Core Insights - Hugel Inc. hosted its global medical symposium H.E.L.F. in Seoul to celebrate the 15th anniversary of its botulinum toxin product Letybo, attracting around 220 professionals from over 25 countries, marking the highest representation at a Hugel event [1][3]. Group 1: Event Overview - The H.E.L.F. symposium has been a flagship event for Hugel since 2013, focusing on sharing insights and clinical techniques in medical aesthetics [2]. - The event featured 10 lectures and discussions across three sessions, covering topics such as botulinum toxin, hyaluronic acid filler, and absorbable suture [4]. Group 2: Session Highlights - The first session addressed personalized aesthetics and adapting Korean medical aesthetics to global markets, featuring speakers from various clinics [5]. - The second session focused on facial contouring techniques, with contributions from renowned surgeons in the aesthetic medicine field [6]. - The third session presented the latest clinical cases and strategies using Letybo, concluding with a panel discussion [6]. Group 3: Company Positioning - Hugel aims to drive the K-Beauty movement by providing integrated solutions in medical aesthetics, emphasizing its commitment to advancing the industry through academic initiatives and knowledge exchange [7]. - Established in 2001, Hugel specializes in injectables for skin rejuvenation and is a market leader in South Korea, with regulatory approvals in the US, China, and Europe [8]. - The company has expanded its presence to approximately 70 countries and operates nine global subsidiaries, positioning itself for continued growth and market expansion [8].